RC
Rabindra Chakraborty
About Rabindra Chakraborty
Data last updated:
Rabindra Chakraborty is a Whole-Time Director at Chromogenic Life Sciences (India) Private Limited (since 2021) and Director at Trilogy Analytical Laboratory Private Limited (since 2021). The companies operate in Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹5.66 Cr; the largest is Chromogenic Life Sciences (India) Private Limited at ₹3.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chromogenic Life Sciences (India) Private Limited U24232TG2011PTC072156 | Whole-Time Director | 24 May 2021 | 2011 | ₹3.91 Cr (FY 2024) | Active |
| Trilogy Analytical Laboratory Private Limited U24132TG2015PTC098389 | Director | 26 Apr 2021 | 2015 | ₹1.75 Cr (FY 2021) | Active |
Board colleagues of Rabindra Chakraborty
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shivani Bhadresh Desai | 07711078 | Chromogenic Life Sciences (India) Private Limited , Trilogy Analytical Laboratory Private Limited | Whole-Time Director |
| Ryan James Malone | 07494333 | Trilogy Analytical Laboratory Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rabindra Chakraborty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rabindra Chakraborty
Rabindra Chakraborty currently holds 2 directorships: Chromogenic Life Sciences (India) Private Limited (Whole-Time Director, since 24 May 2021, revenue ₹3.91 Cr (FY 2024)); Trilogy Analytical Laboratory Private Limited (Director, since 26 Apr 2021, revenue ₹1.75 Cr (FY 2021)).
Rabindra Chakraborty was first appointed on 26 Apr 2021 as Director at Trilogy Analytical Laboratory Private Limited.
The 2 current companies of Rabindra Chakraborty that report revenue have a combined latest revenue of ₹5.66 Cr: Chromogenic Life Sciences (India) Private Limited ₹3.91 Cr (FY 2024); Trilogy Analytical Laboratory Private Limited ₹1.75 Cr (FY 2021).
The current boards of Rabindra Chakraborty's companies include Shivani Bhadresh Desai (Chromogenic Life Sciences (India) Private Limited), Ryan James Malone (Trilogy Analytical Laboratory Private Limited).